Literature DB >> 21784640

Staphylococcal biofilm disassembly.

Blaise R Boles1, Alexander R Horswill.   

Abstract

Staphylococcus aureus and Staphylococcus epidermidis are a frequent cause of biofilm-associated infections that are a tremendous burden on our healthcare system. Staphylococcal biofilms exhibit extraordinary resistance to antimicrobial killing, limiting the efficacy of antibiotic therapy, and surgical intervention is often required to remove infected tissues or implanted devices. Recent work has provided new insight into the molecular basis of biofilm development in these opportunistic pathogens. Extracellular bacterial products, environmental conditions, and polymicrobial interactions have all been shown to influence profoundly the ability of these bacteria to colonize and disperse from clinically relevant surfaces. We review new developments in staphylococcal biofilm disassembly and set them in the context of potential strategies to control biofilm infections.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21784640      PMCID: PMC3164736          DOI: 10.1016/j.tim.2011.06.004

Source DB:  PubMed          Journal:  Trends Microbiol        ISSN: 0966-842X            Impact factor:   17.079


  58 in total

Review 1.  Peptide signaling in the staphylococci.

Authors:  Matthew Thoendel; Jeffrey S Kavanaugh; Caralyn E Flack; Alexander R Horswill
Journal:  Chem Rev       Date:  2010-12-21       Impact factor: 60.622

2.  D-amino acids trigger biofilm disassembly.

Authors:  Ilana Kolodkin-Gal; Diego Romero; Shugeng Cao; Jon Clardy; Roberto Kolter; Richard Losick
Journal:  Science       Date:  2010-04-30       Impact factor: 47.728

3.  Staphylococcus epidermidis Esp inhibits Staphylococcus aureus biofilm formation and nasal colonization.

Authors:  Tadayuki Iwase; Yoshio Uehara; Hitomi Shinji; Akiko Tajima; Hiromi Seo; Koji Takada; Toshihiko Agata; Yoshimitsu Mizunoe
Journal:  Nature       Date:  2010-05-20       Impact factor: 49.962

4.  Implications of endotracheal tube biofilm for ventilator-associated pneumonia.

Authors:  C G Adair; S P Gorman; B M Feron; L M Byers; D S Jones; C E Goldsmith; J E Moore; J R Kerr; M D Curran; G Hogg; C H Webb; G J McCarthy; K R Milligan
Journal:  Intensive Care Med       Date:  1999-10       Impact factor: 17.440

5.  Staphylococcus epidermidis surfactant peptides promote biofilm maturation and dissemination of biofilm-associated infection in mice.

Authors:  Rong Wang; Burhan A Khan; Gordon Y C Cheung; Thanh-Huy L Bach; Max Jameson-Lee; Kok-Fai Kong; Shu Y Queck; Michael Otto
Journal:  J Clin Invest       Date:  2010-12-06       Impact factor: 14.808

Review 6.  Modality of bacterial growth presents unique targets: how do we treat biofilm-mediated infections?

Authors:  Paul D Fey
Journal:  Curr Opin Microbiol       Date:  2010-09-29       Impact factor: 7.934

7.  Vancomycin susceptibility trends and prevalence of heterogeneous vancomycin-intermediate Staphylococcus aureus in clinical methicillin-resistant S. aureus isolates.

Authors:  Adam M Pitz; Fang Yu; Elizabeth D Hermsen; Mark E Rupp; Paul D Fey; Keith M Olsen
Journal:  J Clin Microbiol       Date:  2010-10-20       Impact factor: 5.948

8.  Impact of the agr quorum-sensing system on adherence to polystyrene in Staphylococcus aureus.

Authors:  C Vuong; H L Saenz; F Götz; M Otto
Journal:  J Infect Dis       Date:  2000-10-13       Impact factor: 5.226

9.  Cell wall thickening is not a universal accompaniment of the daptomycin nonsusceptibility phenotype in Staphylococcus aureus: evidence for multiple resistance mechanisms.

Authors:  Soo-Jin Yang; Cynthia C Nast; Nagendra N Mishra; Michael R Yeaman; Paul D Fey; Arnold S Bayer
Journal:  Antimicrob Agents Chemother       Date:  2010-05-24       Impact factor: 5.191

10.  Beta toxin catalyzes formation of nucleoprotein matrix in staphylococcal biofilms.

Authors:  Medora J Huseby; Andrew C Kruse; Jeff Digre; Petra L Kohler; Jillian A Vocke; Ethan E Mann; Kenneth W Bayles; Gregory A Bohach; Patrick M Schlievert; Douglas H Ohlendorf; Cathleen A Earhart
Journal:  Proc Natl Acad Sci U S A       Date:  2010-07-26       Impact factor: 11.205

View more
  89 in total

1.  A Human Biofilm-Disrupting Monoclonal Antibody Potentiates Antibiotic Efficacy in Rodent Models of both Staphylococcus aureus and Acinetobacter baumannii Infections.

Authors:  Yan Q Xiong; Angeles Estellés; L Li; W Abdelhady; R Gonzales; Arnold S Bayer; Edgar Tenorio; Anton Leighton; Stefan Ryser; Lawrence M Kauvar
Journal:  Antimicrob Agents Chemother       Date:  2017-09-22       Impact factor: 5.191

2.  Enhancement of photodynamic inactivation of Staphylococcus aureus biofilms by disruptive strategies.

Authors:  Lautaro Gándara; Leandro Mamone; Gabriela Cervini Bohm; Fernanda Buzzola; Adriana Casas
Journal:  Lasers Med Sci       Date:  2017-06-13       Impact factor: 3.161

3.  Antibodies to PhnD inhibit staphylococcal biofilms.

Authors:  Hubert Lam; Augustus Kesselly; Svetlana Stegalkina; Harry Kleanthous; Jeremy A Yethon
Journal:  Infect Immun       Date:  2014-06-23       Impact factor: 3.441

4.  Relative distribution of virulence-associated factors among Australian bovine Staphylococcus aureus isolates: Potential relevance to development of an effective bovine mastitis vaccine.

Authors:  Jully Gogoi-Tiwari; Charlene Babra Waryah; Karina Yui Eto; Modiri Tau; Kelsi Wells; Paul Costantino; Harish Kumar Tiwari; Shrikrishna Isloor; Nagendra Hegde; Trilochan Mukkur
Journal:  Virulence       Date:  2015       Impact factor: 5.882

Review 5.  Staphylococcal Biofilms.

Authors:  Michael Otto
Journal:  Microbiol Spectr       Date:  2018-08

Review 6.  Bacterial Extracellular Polysaccharides in Biofilm Formation and Function.

Authors:  Dominique H Limoli; Christopher J Jones; Daniel J Wozniak
Journal:  Microbiol Spectr       Date:  2015-06

Review 7.  Impact of Environmental Cues on Staphylococcal Quorum Sensing and Biofilm Development.

Authors:  Jeffrey S Kavanaugh; Alexander R Horswill
Journal:  J Biol Chem       Date:  2016-04-21       Impact factor: 5.157

8.  Poly-N-Acetylglucosamine Production by Staphylococcus epidermidis Cells Increases Their In Vivo Proinflammatory Effect.

Authors:  Pedro Ferreirinha; Begoña Pérez-Cabezas; Alexandra Correia; Bruna Miyazawa; Angela França; Virgínia Carvalhais; Augusto Faustino; Anabela Cordeiro-da-Silva; Luzia Teixeira; Gerald B Pier; Nuno Cerca; Manuel Vilanova
Journal:  Infect Immun       Date:  2016-09-19       Impact factor: 3.441

9.  Staphylococcus epidermidis Esp degrades specific proteins associated with Staphylococcus aureus biofilm formation and host-pathogen interaction.

Authors:  Shinya Sugimoto; Takeo Iwamoto; Koji Takada; Ken-Ichi Okuda; Akiko Tajima; Tadayuki Iwase; Yoshimitsu Mizunoe
Journal:  J Bacteriol       Date:  2013-01-11       Impact factor: 3.490

10.  Flavone reduces the production of virulence factors, staphyloxanthin and α-hemolysin, in Staphylococcus aureus.

Authors:  Jin-Hyung Lee; Joo-Hyeon Park; Moo Hwan Cho; Jintae Lee
Journal:  Curr Microbiol       Date:  2012-09-11       Impact factor: 2.188

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.